OncoMark Articles in Company News Section. http://www.oncomark.com SpeckCMS en 1440 Sat, 29 Apr 2017 06:00:50 March 2017: Prof. William Gallagher Awarded Prestigious Medal for Outstanding Contribution to Irish Cancer Research http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=D0122306-0D07-42E6-9C0B48393D77B443 D0122306-0D07-42E6-9C0B48393D77B443 Congratulations to Professor William Gallagher, who was the inaugural recipient of the Irish Association of Cancer Research (IACR) Cancer Research Medal at the annual IACR Conference held in Kilkenny on 22nd-24th February 2017. This prestigious award recognises his outstanding contribution to the cancer research community in Ireland throughout his career. Fri, 21 Apr 2017 08:53:26 Feb 2017: OncoMark Secures €2.1 Million Investment to Commercialise New Diagnostic Test for Breast Cancer http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=3E5F25A8-B244-46F2-A862608220D4B953 3E5F25A8-B244-46F2-A862608220D4B953 OncoMasTR test to launch in 2018 and will reduce the number of patients receiving unnecessary chemotherapy Wed, 15 Feb 2017 08:24:34 Oct 2016: OncoMark wins award at industry event in Brussels! http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=F5EFF69C-D1D9-6D29-F8B107983CED0781 F5EFF69C-D1D9-6D29-F8B107983CED0781  Mr Des O'Leary, OncoMark's CEO, pitched to an audience of CEOs from more than 400 SMEs from around Europe. Mon, 24 Oct 2016 10:54:17 April 2016 - OncoMasTR assay for breast cancer featured in the Medical Independent http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C8FDF5F-B28F-E78B-1ECDB7227CD7C1C4 4C8FDF5F-B28F-E78B-1ECDB7227CD7C1C4 Prof. William Gallagher describes the OncoMasTR assay for breast cancer in the Medical Independent Wed, 21 Sep 2016 12:55:18 April 2016 - OncoMasTR assay for breast cancer featured in the Irish Examiner http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C877FD0-E8D8-28E5-F994065A0EEFAAF7 4C877FD0-E8D8-28E5-F994065A0EEFAAF7 The Irish Examiner interviews OncoMark's Chief Scientific Officer about the OncoMasTR assay for breast cancer Wed, 21 Sep 2016 12:43:03 November 2015 - OncoMark featured in The Sunday Times http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C7C0C0E-CC18-33E5-1BC796C46A895A8E 4C7C0C0E-CC18-33E5-1BC796C46A895A8E OncoMark's CEO Mr Desmond O'Leary was interviewed for the Sunday Times Wed, 21 Sep 2016 12:29:19 September 2015 - OncoMark profiled in 'Ones to Watch' article in Business & Finance http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=4C76332C-F3A0-EA7E-753F476752633307 4C76332C-F3A0-EA7E-753F476752633307 OncoMark have been profiled in the 'Ones to Watch' feature in Business & Finance Wed, 21 Sep 2016 12:22:45 September 2015 - OncoMark are awarded €2.7 million by the European Commission to develop a diagnostic assay for breast cancer http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=AD5EE424-B0AC-14DA-54DB9BD828522D6B AD5EE424-B0AC-14DA-54DB9BD828522D6B  OncoMark are pleased to announce they have been awarded €2.7 million by the European Commission, for the commercial development of a new Diagnostic test for breast cancer patients. Tue, 08 Sep 2015 15:35:21 August 2015- Mr Desmond O'Leary joins OncoMark as Chief Executive http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=FE82DC28-EF33-FC99-377AB569F6854D8C FE82DC28-EF33-FC99-377AB569F6854D8C We are pleased to announce the appointment of Mr Desmond O Leary to the position of Chief Executive Officer of OncoMark. Mr O Leary is an experienced executive with over 20 years in the diagnostic industry. He will lead OncoMark through the next phase of development to commercialise prognostics tests in the Oncology arena and penetrate a global market. Wed, 05 Aug 2015 16:38:35 February 2014 - Oncomark Research invited to speak at annual meeting of the IACR http://www.oncomark.com/rss.cfm?app=oncomark&type=Article&id=DE0E23AE-0524-A5CC-7D62A424769D47EF DE0E23AE-0524-A5CC-7D62A424769D47EF Dr Maria Prencipe is invited to speak at the annual meeting of the IACR. Mon, 12 Jan 2015 12:15:18